domestic site?” is “Yes” N N NIH, 1.0 Both E New PHS Section 034.7.5 Provide error for For Study titled < Rule Human 3 a Clinical Trial Study Title>, a Data – K12 October Subject Study if Data and Safety 2017 and and and Safety Monitoring Plan Release Clinical Monitoring Plan attachment is = “R" Trial is not provided required since you or Plans answered Yes to "O" or "I") questions 1.4.a-1.4.d AND 3.3 Data in the Clinical Trial and Questionnaire. Safety to Plan 1.4a 1.4d is ALL PHS Section 034.7.6 N N NIH, 1.0 Both Provide error for For study titled E New Rule Human 3 a Clinical Trial <Study Title>, a – K12 October Subject Study Record if response to the 2017 and and response to the question, a “Will Release Clinical question a Data and Safety “Will = “R" Trial Data and Safety Monitoring Board be or Plans Monitoring appointed for this "O") AND Board be is required study?” 3.4 Will appointed for since you answered a Data to questions “Yes” to
domestic site?” is “Yes” PHS Human Subject and Clinical Trial Section 3 – and Plans 3.3 Data and Safety Plan 034.7.5 N N NIH, 1.0 = “R" or "O" or "I") AND to 1.4a 1.4d is ALL K12 Both Provide error for a Clinical Trial Study if Data and Safety Monitoring Plan is not provided For Study titled < Study Title>, a Data and Safety Monitoring Plan attachment is required since you answered Yes to questions 1.4.a-1.4.d in the Clinical Trial Questionnaire. E New Rule October 2017 Release PHS Human Subject and Clinical Trial Section 3 – and Plans 3.4 Will a Data 034.7.6 N N NIH, 1.0 = “R" or "O") AND to K12 Both Provide error for a Clinical Trial Study Record if response to the question “Will a Data and Safety Monitoring Board be appointed for For study titled <Study Title>, a response to the question, “Will a Data and Safety Monitoring Board be appointed for this study?” is required since you answered “Yes” to questions E New Rule October 2017 Release
eSub-validations-draft-10-10-2017.docx